In this special edition of Plant Rants, we take a look at the TGA’s 2025 consultation paper.
With the help of our AI journalists Charlene and Chadwick, this episode peels back the layers of bias and risk-centric framing.
So whose voices are being heard? Whose experiences actually count? And how do the lived realities of thousands of patients, who are seeing life-changing benefits from medicinal cannabis, stack up against the official risk-heavy framing of regulators?
This episode deep dives into:
- The consultation’s overwhelming focus on risks and hazards.
- Real-world patient outcomes, like massive opioid reduction, improved quality of life, and even return-to-work rates.
- Why ignoring dosing, supervision, and episodic use misses the fundamentals of pharmacology.
- Join The Patients movement fighting to ensure lived experience is central to the policy conversation.
Episode 5